Joseph Rovig (NOV) files Form 144 to sell 79,086 and 72,000 shares

Rhea-AI Filing Summary

Joseph Rovig filed a Form 144 reporting proposed sales of Common stock related to stock option exercises dated 02/23/2026, listing amounts of 79,086 and 72,000 shares. The filing also shows a prior sale of 40,000 shares on 11/24/2025 for $589,832.00.

Insights

Insider Transactions Analyst

Form 144 lists planned dispositions tied to option exercises and a recent sale.

The filing records two separate proposed sales of Common stock on 02/23/2026 described as Stock Option Exercise transactions, with line items of 79,086 and 72,000 shares. It also discloses a completed sale of 40,000 shares on 11/24/2025 for $589,832.00.

Timing and cash‑flow treatment for the planned 02/23/2026 dispositions are stated as related to option exercises; additional details about execution method or net proceeds are not shown in the excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	151086	3046694.52	360404544	02/23/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2026	Stock Option Exercise	Issuer			79086	02/23/2026	Cash
Common	02/23/2026	Stock Option Exercise	Issuer			72000	02/23/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOSEPH ROVIG 10353 RICHMOND AVE HOUSTON TX 77042	Common	11/24/2025	40000	589832.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does NOV Form 144 filed by Joseph Rovig report?

It reports planned sales related to stock option exercises on 02/23/2026, showing 79,086 and 72,000 shares. It also lists a prior sale of 40,000 shares on 11/24/2025 for $589,832.00.

How many shares did Joseph Rovig sell recently under Form 144 for NOV?

The filing shows a completed sale of 40,000 shares on 11/24/2025 with aggregate proceeds of $589,832.00. Planned dispositions of 79,086 and 72,000 shares are listed for 02/23/2026.

Are the planned NOV sales tied to option exercises or open‑market trades?

The excerpt labels the planned transactions as Stock Option Exercise, indicating the dispositions are related to exercises rather than explicitly described open‑market trades. Execution details are not provided in the excerpt.

Does the Form 144 indicate how proceeds will be handled for NOV transactions?

The filing entries reference Cash in connection with the stock option exercises, but the excerpt does not specify net proceeds recipients or further cash‑flow allocation details.

What date are the planned NOV dispositions scheduled for?

Planned dispositions are dated 02/23/2026 in the excerpt, and a prior sale occurred on 11/24/2025. No additional timing details are provided.